Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA pseudouridine synthase D3 (RPUSD3) is a mitochondrial protein that belongs to the family of RNA pseudouridine synthases, which are enzymes responsible for the post-transcriptional modification of specific uridines into pseudouridines in RNA[1][4]. However, RPUSD3 is distinct within its family because it lacks the conserved catalytic aspartate residue required for enzymatic pseudouridylation activity, suggesting it is not an active pseudouridine synthase[1]. Despite this, RPUSD3 plays a crucial non-catalytic role in mitochondrial RNA metabolism, particularly in the assembly and function of the mitochondrial ribosome, possibly by facilitating proper RNA folding or acting as a structural RNA-binding protein[1][5][3]. Depletion of RPUSD3 results in decreased stability of specific mitochondrial RNAs (including 16S rRNA), impaired mitochondrial protein synthesis, and dysfunctional oxidative phosphorylation, which can compromise cell viability[2][6][3]. RPUSD3 is thus essential for maintaining mitochondrial translation and cellular energy metabolism, but is not currently established as a drug target or clinical biomarker.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA pseudouridine synthase D3 (RPUSD3).